All articles tagged with #monash university
Researchers at Monash University have developed a new graphene-based material called multiscale reduced graphene oxide (M-rGO) that significantly enhances supercapacitors, enabling them to store energy comparable to batteries while offering rapid charging and high power output, with potential for commercial applications in electric vehicles and electronics.
Researchers in Australia have developed a safe, affordable, and high-performance water-based flow battery that could replace expensive lithium-ion systems for household solar energy storage, potentially on the market within a few years.
Research from Monash University suggests that cheap blood pressure drugs called beta blockers may help slow the progression of aggressive triple-negative breast cancer by inhibiting a gene called HOXC12, potentially offering a low-cost treatment option. Further studies are needed to confirm if this approach can be used at diagnosis to identify patients who would benefit from beta blocker therapy.
Physicists at Monash University have published a review in Progress in Particle and Nuclear Physics, detailing their groundbreaking work on understanding the universe's fundamental physics through gravitational waves (GWs) and first-order phase transitions (FOPTs) in the early cosmos. The review provides a comprehensive guide for particle physicists to explore GW phenomenology, emphasizing the intricate journey from particle physics models to observable GWs induced by vacuum decays during FOPTs. The future holds immense potential for space- and ground-based detectors to reveal unseen phenomena, potentially emanating from FOPTs, promising to unlock the secrets of new physics beyond the standard model.
Researchers at Monash University have developed an experimental therapy for lupus using regulatory T cells from healthy individuals to "fix" defective cells that cause the autoimmune disease. The therapy was successful in halting the progression of lupus kidney disease in preclinical models without the need for toxic immunosuppressant drugs. The researchers hope that this targeted T regulatory cell therapy could eventually be used to treat over 100 other autoimmune conditions. Human clinical trials are expected to start in 2026 to determine the viability of this treatment method. While the findings are promising, further research and development are needed before human trials can commence.
Researchers from the University of Liège and Monash University have confirmed the existence of a third protoplanet, HD 169142 b, using data from the SPHERE instrument of the European Southern Observatory. The protoplanet is located in the disk of gas and dust surrounding HD 169142, a star 374 light years from our solar system. The discovery was made possible by advanced image processing tools developed by the PSILab of the University of Liège. The protoplanet is still gathering material and is buried in a significant amount of dust, which could be in the form of a circumplanetary disk. Further characterization of the protoplanet could be obtained through future observations with the James Webb Space Telescope.